Vital KSK Holdings, Inc. Stock

Equities

3151

JP3778280002

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-04-23 am EDT 5-day change 1st Jan Change
1,208 JPY +0.17% Intraday chart for Vital KSK Holdings, Inc. -1.95% +15.71%
Sales 2022 577B 3.73B Sales 2023 580B 3.75B Capitalization 46.3B 299M
Net income 2022 4.77B 30.82M Net income 2023 4.83B 31.22M EV / Sales 2022 0.04 x
Net cash position 2022 15.12B 97.72M Net cash position 2023 8.78B 56.74M EV / Sales 2023 0.06 x
P/E ratio 2022
8.36 x
P/E ratio 2023
9.64 x
Employees 3,719
Yield 2022
3.27%
Yield 2023
4.36%
Free-Float 63.35%
More Fundamentals * Assessed data
Dynamic Chart
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024 CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023. CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million. CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023 CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million. CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan. CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023. CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million. CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024 CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024 CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023. CI
Vital KSK Announces Voting Results CI
More news
1 day+0.17%
1 week-1.95%
Current month-3.82%
1 month-5.03%
3 months+9.52%
6 months+22.39%
Current year+15.71%
More quotes
1 week
1 139.00
Extreme 1139
1 214.00
1 month
1 139.00
Extreme 1139
1 304.00
Current year
1 019.00
Extreme 1019
1 378.00
1 year
878.00
Extreme 878
1 378.00
3 years
635.00
Extreme 635
1 378.00
5 years
635.00
Extreme 635
1 378.00
10 years
635.00
Extreme 635
1 378.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 09-03-31
Director of Finance/CFO - -
Chairman 75 09-03-31
Members of the board TitleAgeSince
Chairman 75 09-03-31
Director/Board Member 81 09-03-31
Chief Executive Officer 70 09-03-31
More insiders
Date Price Change Volume
24-04-23 1,208 +0.17% 63 200
24-04-22 1,206 +2.64% 52,500
24-04-19 1,175 -2.00% 68,800
24-04-18 1,199 +1.61% 31,500
24-04-17 1,180 -1.67% 80,300

Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT

More quotes
VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.
Calendar
More about the company